Indira Basu

1.6k total citations
28 papers, 772 citations indexed

About

Indira Basu is a scholar working on Epidemiology, Infectious Diseases and Endocrinology. According to data from OpenAlex, Indira Basu has authored 28 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Infectious Diseases and 8 papers in Endocrinology. Recurrent topics in Indira Basu's work include Mycobacterium research and diagnosis (9 papers), Tuberculosis Research and Epidemiology (8 papers) and Vibrio bacteria research studies (7 papers). Indira Basu is often cited by papers focused on Mycobacterium research and diagnosis (9 papers), Tuberculosis Research and Epidemiology (8 papers) and Vibrio bacteria research studies (7 papers). Indira Basu collaborates with scholars based in New Zealand, Australia and India. Indira Basu's co-authors include John D. Fraser, Ries J. Langley, Bruce D. Wines, Thomas Proft, Youhei Takeda, Sujit Bhattacharya, Shinji Yamasaki, Sally Roberts, James E. Bower and Deborah A. Williamson and has published in prestigious journals such as The Journal of Immunology, Journal of Molecular Biology and Journal of Clinical Microbiology.

In The Last Decade

Indira Basu

28 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indira Basu New Zealand 12 318 282 265 191 154 28 772
Rachael D. Aubert United States 12 256 0.8× 106 0.4× 636 2.4× 306 1.6× 173 1.1× 17 1.2k
W H Benjamin United States 18 304 1.0× 193 0.7× 147 0.6× 295 1.5× 219 1.4× 29 1.0k
Marie Wrande Sweden 8 167 0.5× 97 0.3× 174 0.7× 98 0.5× 410 2.7× 13 699
Nikolaus Ackermann Germany 17 362 1.1× 171 0.6× 59 0.2× 190 1.0× 315 2.0× 29 905
Kai Michaelis Germany 14 161 0.5× 221 0.8× 113 0.4× 155 0.8× 336 2.2× 21 837
S Sarasombath Thailand 13 536 1.7× 104 0.4× 267 1.0× 147 0.8× 149 1.0× 40 1.1k
Chengsong Wan China 17 355 1.1× 138 0.5× 69 0.3× 181 0.9× 230 1.5× 66 806
Frederick J. Cassels United States 19 429 1.3× 485 1.7× 248 0.9× 91 0.5× 388 2.5× 37 1.2k
Mario Alberto Flores‐Valdez Mexico 17 491 1.5× 177 0.6× 268 1.0× 219 1.1× 199 1.3× 67 827
Ling Yan China 18 186 0.6× 338 1.2× 169 0.6× 521 2.7× 378 2.5× 43 1.2k

Countries citing papers authored by Indira Basu

Since Specialization
Citations

This map shows the geographic impact of Indira Basu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indira Basu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indira Basu more than expected).

Fields of papers citing papers by Indira Basu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indira Basu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indira Basu. The network helps show where Indira Basu may publish in the future.

Co-authorship network of co-authors of Indira Basu

This figure shows the co-authorship network connecting the top 25 collaborators of Indira Basu. A scholar is included among the top collaborators of Indira Basu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indira Basu. Indira Basu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hardaker, Natalie, Doug King, Patria Hume, et al.. (2024). Female RNA concussion (FeRNAC) study: assessing hormone profiles and salivary RNA in females with concussion by emergency departments in New Zealand: a study protocol. BMC Neurology. 24(1). 149–149. 1 indexed citations
2.
3.
Roberts, Sally, Matthew Blakiston, Mark B. Schultz, et al.. (2022). Epidemiology of carbapenem resistant Acinetobacter baumannii in New Zealand. New Zealand Medical Journal. 135(1561). 76–82. 5 indexed citations
4.
Basu, Indira, et al.. (2020). Helicobacter cinaedi bacteremia in a returning traveler. IDCases. 21. e00910–e00910. 3 indexed citations
5.
Basu, Indira, et al.. (2020). Evaluation of extraction and amplification assays for the detection of SARS-CoV-2 at Auckland Hospital laboratory during the COVID-19 outbreak in New Zealand. Journal of Virological Methods. 289. 114042–114042. 5 indexed citations
6.
Vesty, Anna, et al.. (2020). Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand. Emerging infectious diseases. 26(2). 332–335. 11 indexed citations
7.
Basu, Indira, et al.. (2018). Utility of whole genome sequencing for multidrug resistant Mycobacterium tuberculosis isolates in a reference TB laboratory in New Zealand.. PubMed. 131(1487). 15–22. 1 indexed citations
8.
Aogáin, Micheál Mac, Sanjay Gautam, James E. Bower, Indira Basu, & Ronan O’Toole. (2016). Draft Genome Sequence of a New Zealand Rangipo Strain of Mycobacterium tuberculosis. Genome Announcements. 4(4). 4 indexed citations
9.
Basu, Indira, et al.. (2015). False-negative BD MGIT™ TBc Identification Test results in routine tuberculosis diagnosis: a New Zealand perspective. The International Journal of Tuberculosis and Lung Disease. 19(9). 1073–1075. 4 indexed citations
10.
Aogáin, Micheál Mac, James E. Bower, Indira Basu, Joshua T. Freeman, & Ronan O’Toole. (2015). Draft Genome Sequence of a Drug-Susceptible New Zealand Isolate of Mycobacterium tuberculosis Lineage 3. Genome Announcements. 3(3). 1 indexed citations
11.
Basu, Indira, Collette Bromhead, Michelle Balm, et al.. (2015). Lymphogranuloma venereum in men who have sex with men: evidence of local transmission in New Zealand.. PubMed. 128(1410). 25–9. 2 indexed citations
12.
Yen, Seiha, Julienne E. Bower, Jane Freeman, Indira Basu, & Ronan O’Toole. (2013). Phylogenetic lineages of tuberculosis isolates in New Zealand and their association with patient demographics. The International Journal of Tuberculosis and Lung Disease. 17(7). 892–897. 13 indexed citations
13.
14.
Williamson, Deborah A., et al.. (2012). An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagnostic Microbiology and Infectious Disease. 74(2). 207–209. 68 indexed citations
15.
Baker, Heather M., Indira Basu, Matthew Chung, et al.. (2007). Crystal Structures of the Staphylococcal Toxin SSL5 in Complex with Sialyl Lewis X Reveal a Conserved Binding Site that Shares Common Features with Viral and Bacterial Sialic Acid Binding Proteins. Journal of Molecular Biology. 374(5). 1298–1308. 57 indexed citations
16.
Garg, Pallavi, Soumen Chakraborty, Indira Basu, et al.. (2000). Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992–7 in Calcutta, India. Epidemiology and Infection. 124(3). 393–399. 104 indexed citations
17.
Basu, Indira, Rupak Mitra, Pradip Saha, et al.. (1999). Morphological and cytoskeletal changes caused by non-membrane damaging cytotoxin ofVibrio choleraeon Int 407 and HeLa cells. FEMS Microbiology Letters. 179(2). 255–263. 10 indexed citations
18.
Mukherjee, Swarupananda, et al.. (1998). STD/HIV intervention with sex workers in West Bengal, India.. PubMed. 12 Suppl B. S101–8. 55 indexed citations
19.
Mitra, Rupak, Pradip Saha, Indira Basu, et al.. (1998). Characterization of non-membrane-damaging cytotoxin of non-toxigenicVibrio choleraeO1 and its relevance to disease. FEMS Microbiology Letters. 169(2). 331–339. 4 indexed citations
20.
Sharma, Charu, M. Thungapathra, Asit Ranjan Ghosh, et al.. (1998). Molecular Analysis of Non-O1, Non-O139 Vibrio cholerae Associated with an Unusual Upsurge in the Incidence of Cholera-Like Disease in Calcutta, India. Journal of Clinical Microbiology. 36(3). 756–763. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachael D. Aubert Breakdown of academic impact, for papers by W H Benjamin Breakdown of academic impact, for papers by Marie Wrande Breakdown of academic impact, for papers by Nikolaus Ackermann Breakdown of academic impact, for papers by Kai Michaelis Breakdown of academic impact, for papers by S Sarasombath Breakdown of academic impact, for papers by Chengsong Wan Breakdown of academic impact, for papers by Frederick J. Cassels Breakdown of academic impact, for papers by Mario Alberto Flores‐Valdez Breakdown of academic impact, for papers by Ling Yan
Rankless by CCL
2026